132 related articles for article (PubMed ID: 38314191)
21. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias.
Balduini CL; Pecci A; Savoia A
Br J Haematol; 2011 Jul; 154(2):161-74. PubMed ID: 21542825
[TBL] [Abstract][Full Text] [Related]
22. [May-Hegglin anomaly--from genome research to clinical laboratory].
Kunishima S
Rinsho Byori; 2003 Sep; 51(9):898-904. PubMed ID: 14560660
[TBL] [Abstract][Full Text] [Related]
23. MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the Disorder.
Zaninetti C; De Rocco D; Giangregorio T; Bozzi V; Demeter J; Leoni P; Noris P; Ryhänen S; Barozzi S; Pecci A; Savoia A
Hamostaseologie; 2019 Feb; 39(1):87-94. PubMed ID: 29996171
[TBL] [Abstract][Full Text] [Related]
24. Successful renal transplantation in MYH9-related disorder with severe macrothrombocytopenia: first report in Korea.
Min SY; Ahn HJ; Park WS; Kim JW
Transplant Proc; 2014; 46(2):654-6. PubMed ID: 24656038
[TBL] [Abstract][Full Text] [Related]
25. A genome-first approach to rare variants in hypertrophic cardiomyopathy genes MYBPC3 and MYH7 in a medical biobank.
Park J; Packard EA; Levin MG; Judy RL; ; Damrauer SM; Day SM; Ritchie MD; Rader DJ
Hum Mol Genet; 2022 Mar; 31(5):827-837. PubMed ID: 34542152
[TBL] [Abstract][Full Text] [Related]
26. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes.
Arrondel C; Vodovar N; Knebelmann B; Grünfeld JP; Gubler MC; Antignac C; Heidet L
J Am Soc Nephrol; 2002 Jan; 13(1):65-74. PubMed ID: 11752022
[TBL] [Abstract][Full Text] [Related]
27. Macrothrombocytopenia With Döhle Body-Like Granulocyte Inclusions: A Case Report of May-Hegglin Anomaly in a 33-Year-Old White Woman With an Update on the Molecular Findings of MYH9-Related Disease.
Ruhoy SM; Yates A
Lab Med; 2016 Aug; 47(3):246-50. PubMed ID: 27353381
[TBL] [Abstract][Full Text] [Related]
28. Familial cases with MYH9 disorders caused by MYH9 S96L mutation.
Murayama S; Akiyama M; Namba H; Wada Y; Ida H; Kunishima S
Pediatr Int; 2013 Feb; 55(1):102-4. PubMed ID: 23409987
[TBL] [Abstract][Full Text] [Related]
29. Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease.
Pal K; Nowak R; Billington N; Liu R; Ghosh A; Sellers JR; Fowler VM
Blood; 2020 May; 135(21):1887-1898. PubMed ID: 32315395
[TBL] [Abstract][Full Text] [Related]
30. Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafness.
Kunishima S; Matsushita T; Shiratsuchi M; Ikuta T; Nishimura J; Hamaguchi M; Naoe T; Saito H
Eur J Haematol; 2005 Jan; 74(1):1-5. PubMed ID: 15613099
[TBL] [Abstract][Full Text] [Related]
31. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH
Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612
[TBL] [Abstract][Full Text] [Related]
32. A D1424N mutation in the MYH9 gene results in macrothrombocytopenia and granulocytic inclusion bodies in a Chinese inherited macrothrombocytopenia pedigree.
Guo X; Lian X; Zhang W; Hao J
Clin Chem Lab Med; 2018 Jun; 56(7):e171-e173. PubMed ID: 29451856
[No Abstract] [Full Text] [Related]
33. Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes.
D'Apolito M; Guarnieri V; Boncristiano M; Zelante L; Savoia A
Gene; 2002 Mar; 286(2):215-22. PubMed ID: 11943476
[TBL] [Abstract][Full Text] [Related]
34. A novel mutation of the MYH7 gene in a patient with hypertrophic cardiomyopathy.
Goel N; Huddleston CB; Fiore AC
Turk J Pediatr; 2018; 60(3):315-318. PubMed ID: 30511546
[TBL] [Abstract][Full Text] [Related]
35. A Splice Variant of the
Myasnikov RP; Kulikova OV; Meshkov AN; Bukaeva AA; Kiseleva AV; Ershova AI; Petukhova AV; Divashuk MG; Zotova ED; Sotnikova EA; Abisheva AA; Muraveva AV; Koretskiy SN; Popov SV; Utkina MV; Snigir EA; Mitrofanov SI; Konureeva KD; Mershina EA; Sinitsyn VE; Yudin SM; Drapkina OM
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292635
[TBL] [Abstract][Full Text] [Related]
36. Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder.
Wasano K; Matsunaga T; Ogawa K; Kunishima S
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3547-3552. PubMed ID: 26942920
[TBL] [Abstract][Full Text] [Related]
37. Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.
Arif AR; Zhao M; Chen W; Xue M; Luo S; Wang Y
Platelets; 2022 Nov; 33(8):1307-1311. PubMed ID: 35791514
[TBL] [Abstract][Full Text] [Related]
38. Inherited Macrothrombocytopenia: Correlating Morphology, Epidemiology, Molecular Pathology and Clinical Features.
Ghosh K; Bhattacharya M; Chowdhury R; Mishra K; Ghosh M
Indian J Hematol Blood Transfus; 2018 Jul; 34(3):387-397. PubMed ID: 30127546
[TBL] [Abstract][Full Text] [Related]
39. Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation.
Winkler CA; Nelson G; Oleksyk TK; Nava MB; Kopp JB
Semin Nephrol; 2010 Mar; 30(2):111-25. PubMed ID: 20347641
[TBL] [Abstract][Full Text] [Related]
40. Clinical and molecular genetic analysis of a family with macrothrombocytopenia and early onset sensorineural hearing loss.
Mhatre AN; Janssens S; Nardi MA; Li Y; Lalwani AK
Eur J Med Genet; 2009; 52(4):185-90. PubMed ID: 19285578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
